Find uplifting stories about heroes, innovations, and solutions
4445 results for "nhs approval"
Around 20 people in England with a debilitating genetic condition can now access the first treatment that targets the root cause of their disease. The NHS will provide pegzilarginase to patients with arginase-1 deficiency after breakthrough approval.
Patients in England with advanced gastrointestinal stromal tumors now have a fourth treatment option after NHS approved ripretinib, a drug that extends life with fewer side effects. For those who've exhausted all other therapies and faced weeks to live, this approval brings genuine hope.
Boys living with Duchenne muscular dystrophy in England now have access to a new treatment that could extend their ability to walk by up to five years. The NHS has approved givinostat, offering fresh hope to families facing this devastating muscle-wasting disease.
Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy. The approval marks the first new ovarian cancer treatment on the NHS in two decades.
A groundbreaking treatment can now delay type 1 diabetes for up to three years, giving families precious time before symptoms begin. The NHS has approved the first-ever drug that stops the disease in its tracks during early stages.
Hundreds of patients with rare blood cancers in England can now access two breakthrough treatments that work from home or offer better survival odds. The new approvals bring hope to families facing diseases that once had few options.
After two decades without a breakthrough, England's health service has approved a targeted therapy that offers new hope to women with hard-to-treat ovarian cancer. Around 400 patients annually will now access this "biological missile" treatment that doubles as their first option when chemotherapy stops working.
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
The NHS just approved a groundbreaking ovarian cancer treatment that works like a guided missile, targeting only cancer cells while leaving healthy tissue untouched. For women with platinum-resistant ovarian cancer who had almost no options left, this precision medicine marks a genuine turning point. #
Children as young as eight with rare blood cancers now have access to two groundbreaking treatments through NHS England. The new drugs offer hope where other therapies have failed, with some patients able to take treatment at home instead of in hospitals.
A groundbreaking combination treatment for lupus nephritis just won approval in England, offering 12,000 people with kidney damage a real shot at restored health. The therapy works twice as well as current options at bringing kidney function back to normal.
After two decades, women with hard-to-treat ovarian cancer finally have a new option. The targeted therapy offers more precious time with loved ones and dramatically fewer side effects than traditional chemotherapy.
Around 1,500 people with stomach cancer will gain access to a groundbreaking immunotherapy treatment that extends survival and reduces recurrence. It's the first major advance in stomach cancer care in nearly ten years.
A new once-daily pill could transform life for thousands of people in England living with a debilitating heart condition that makes simple activities exhausting. The treatment reached patients two weeks faster than usual thanks to groundbreaking collaboration between health regulators. #
England approved its first new brain tumor treatment in 18 years, offering hope to 300 patients living in fear of their tumors growing. For Sally Penny, the pill has already given her a year without side effects and precious time with her children.
A newly approved pill nearly doubles survival time for patients with advanced pancreatic cancer, offering real hope for one of the deadliest cancer types. The breakthrough targets a protein that drives tumor growth in 95% of pancreatic cancer cases.
Patients with low-grade brain tumors in England and Wales can now access vorasidenib, the first new adult brain tumor treatment approved in the UK in two decades. The drug helps patients delay harsh chemotherapy and radiotherapy treatments while living longer without their disease progressing.
Nearly 30,000 people in England with chronic lung disease will gain access to the first treatment that targets an underlying cause, not just symptoms. The twice-monthly injection cuts severe flare-ups by 30% and could save the NHS millions.
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
Millions of Alzheimer's patients who experience severe agitation now have a safer treatment option after the FDA approved Auvelity, a drug that works differently than risky antipsychotic medications. The approval gives hope to families struggling with one of the disease's most challenging symptoms.
Showing 20 of 4445